Paper40879880
Microglial pyroptosis in neurological disorders: mechanistic crosstalk, metabolic triggers, and therapeutic frontiers.
Kumar R and 6 others. Metab Brain Dis, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Microglial pyroptosis in neurological disorders: mechanistic crosstalk, metabolic triggers, and therapeutic frontiers. Papers, record 40879880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40879880
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microglial pyroptosis in neurological disorders: mechanistic crosstalk, metabolic triggers, and therapeutic frontiers.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pyroptosis | Major topic |
| Microglia | Major topic |
| Nervous System Diseases | Major topic |
| Neurodegenerative Diseases | Major topic |
| Humans | |
| Animals | |
| Inflammasomes |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32861242 | Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis. | J Neuroinflammation | 2020 | https://conductscience.org/library/papers/32861242 | PubMed |
| 2 | 33901504 | Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33901504 | PubMed |
| 3 | 37545507 | Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities. | Front Immunol | 2023 | https://conductscience.org/library/papers/37545507 | PubMed |
| 4 | 34719258 | CCR5 Activation Promotes NLRP1-Dependent Neuronal Pyroptosis via CCR5/PKA/CREB Pathway After Intracerebral Hemorrhage. | Stroke | 2021 | https://conductscience.org/library/papers/34719258 | PubMed |
| 5 | 26375259 | Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. | Nature | 2015 | https://conductscience.org/library/papers/26375259 | PubMed |
| 6 | 30341423 | Pyroptosis versus necroptosis: similarities, differences, and crosstalk. | Cell Death Differ | 2019 | https://conductscience.org/library/papers/30341423 | PubMed |
| 7 | 33405023 | CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway. | Inflammation | 2021 | https://conductscience.org/library/papers/33405023 | PubMed |
| 8 | 34931767 | Methods for monitoring cancer cell pyroptosis. | Cancer Biol Med | 2021 | https://conductscience.org/library/papers/34931767 | PubMed |
| 9 | 39248161 | Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials. | Neural Regen Res | 2025 | https://conductscience.org/library/papers/39248161 | PubMed |
| 10 | 10353249 | Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. | Nature | 1999 | https://conductscience.org/library/papers/10353249 | PubMed |
| 11 | 37277654 | Molecular mechanisms of gasdermin D pore-forming activity. | Nat Immunol | 2023 | https://conductscience.org/library/papers/37277654 | PubMed |
| 12 | 37852103 | The interplay between α-Synuclein and NLRP3 inflammasome in Parkinson's disease. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37852103 | PubMed |
| 13 | 39476537 | The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets. | EBioMedicine | 2024 | https://conductscience.org/library/papers/39476537 | PubMed |
| 14 | 37914099 | Gasdermin D activation in oligodendrocytes and microglia drives inflammatory demyelination in progressive multiple sclerosis. | Brain Behav Immun | 2024 | https://conductscience.org/library/papers/37914099 | PubMed |
| 15 | 31748742 | NLRP3 inflammasome activation drives tau pathology. | Nature | 2019 | https://conductscience.org/library/papers/31748742 | PubMed |
| 16 | 34504660 | From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways. | Comput Struct Biotechnol J | 2021 | https://conductscience.org/library/papers/34504660 | PubMed |
| 17 | 28380370 | A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia. | Cell Metab | 2017 | https://conductscience.org/library/papers/28380370 | PubMed |
| 18 | 38599171 | Innate immune activation in neurodegenerative diseases. | Immunity | 2024 | https://conductscience.org/library/papers/38599171 | PubMed |
| 19 | 23254930 | NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. | Nature | 2013 | https://conductscience.org/library/papers/23254930 | PubMed |
| 20 | 33785842 | Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33785842 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983447 | Regulatory cell death of microglia in common cerebrovascular diseases: mechanism, heterogeneity and therapeutic significance. | J Transl Med | 2026 | https://conductscience.org/library/papers/42983447 | PubMed |
| 42406192 | Dissecting PANoptosis in the Nervous System: A Unified Cell-Death Mechanism Driving Neuroimmune Activation and Chronic Neuroinflammation. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42406192 | PubMed |
| 42220202 | Targeting TLR4-Depended NLRP3 Inflammasome: Sulforaphane's Mechanism in Suppressing Neuroinflammation and Seizures in Epileptic Mice. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/42220202 | PubMed |
| 42018964 | MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/42018964 | PubMed |
| 41898328 | Mitochondrial Dysfunction in the Inflammatory Process of Neurodegenerative Diseases. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898328 | PubMed |
| 41300647 | Neuroinflammation as a Novel Therapeutic Frontier for Sanfilippo Syndrome. | Children (Basel) | 2025 | https://conductscience.org/library/papers/41300647 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| GSDMA | 284110 | PubTator's text mining | https://conductscience.org/library/genes/284110 | NCBI Gene |
| GSDMD | 79792 | PubTator's text mining | https://conductscience.org/library/genes/79792 | NCBI Gene |
| PYCARD | 29108 | PubTator's text mining | https://conductscience.org/library/genes/29108 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40879880
GET https://conductscience.org/api/papers/v1/40879880/references?page=2